154 related articles for article (PubMed ID: 28432016)
21. Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery.
Varan G; Benito JM; Mellet CO; Bilensoy E
Beilstein J Nanotechnol; 2017; 8():1457-1468. PubMed ID: 28900599
[No Abstract] [Full Text] [Related]
22. Development of Nanosuspension Formulations Compatible with Inkjet Printing for the Convenient and Precise Dispensing of Poorly Soluble Drugs.
Leung DH
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214180
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
24. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel.
Bilensoy E; Gürkaynak O; Ertan M; Sen M; Hincal AA
J Pharm Sci; 2008 Apr; 97(4):1519-29. PubMed ID: 17705171
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
26. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
Devalapally H; Duan Z; Seiden MV; Amiji MM
Clin Cancer Res; 2008 May; 14(10):3193-203. PubMed ID: 18483388
[TBL] [Abstract][Full Text] [Related]
27. Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer.
Büyükköroğlu G; Şenel B; Başaran E; Yenilmez E; Yazan Y
Eur J Pharm Biopharm; 2016 Dec; 109():174-183. PubMed ID: 27793757
[TBL] [Abstract][Full Text] [Related]
28. The application of nanosponges to cancer drug delivery.
Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma.
Pei Q; Hu X; Liu S; Li Y; Xie Z; Jing X
J Control Release; 2017 May; 254():23-33. PubMed ID: 28359677
[TBL] [Abstract][Full Text] [Related]
30. Inkjet printing of small molecules, biologics, and nanoparticles.
Chou WH; Gamboa A; Morales JO
Int J Pharm; 2021 May; 600():120462. PubMed ID: 33711471
[TBL] [Abstract][Full Text] [Related]
31. Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes.
Belletti D; Riva G; Tosi G; Forni F; Barozzi P; Luppi M; Vandelli MA; Ruozi B
Int J Pharm; 2011 Jul; 413(1-2):220-8. PubMed ID: 21536117
[TBL] [Abstract][Full Text] [Related]
32. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.
Agüeros M; Espuelas S; Esparza I; Calleja P; Peñuelas I; Ponchel G; Irache JM
Expert Opin Drug Deliv; 2011 Jun; 8(6):721-34. PubMed ID: 21463219
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
34. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
35. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
[TBL] [Abstract][Full Text] [Related]
36. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
37. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
38. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
[TBL] [Abstract][Full Text] [Related]
39. Inkjet-Printed Biofunctional Thermo-Plasmonic Interfaces for Patterned Neuromodulation.
Kang H; Lee GH; Jung H; Lee JW; Nam Y
ACS Nano; 2018 Feb; 12(2):1128-1138. PubMed ID: 29402086
[TBL] [Abstract][Full Text] [Related]
40. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
